ID-Past Residents
Past Residents
| Resident | Year | Project | Position(s) After Residency |
|---|---|---|---|
| Elizabeth Sabo, PharmD, BCPS | 2008-9 | The impact of reporting extended spectrum beta-lactamase production on practitioner antimicrobial selection in Klebsiella bacteremia |
Clinical Pharmacist, Infectious Diseases - Christiana Hospital, Clinical Pharmacist, Infectious Diseases - Pennsylvania Hospital |
| Jenna Ferrara, PharmD, BCPS | 2009-10 | The role of empiric therapy on outcomes in Gram-negative bacteremia |
Clinical Pharmacist, Infectious Diseases - University of Pittsburgh Health System, |
| Thy Le, PharmD, BCPS (AQID) | 2010-11 | Impact of the time to appropriate therapy on outcomes in candidemia |
Clinical Pharmacist, Infectious Diseases - Coney Island Hospital |
| Safia Kuriakose, PharmD, BCPS | 2011-12 | Case-case-control study of patients with carbapenem-resistant and third-generation cephalosporin-resistant Klebsiella pneumoniae bacteremia |
Clinical Pharmacist, Infectious Diseases - St. Joseph’s Medical Center |
| Kimberly Miller, PharmD, BCPS | 2012-13 | Characteristics and cultures of patients with healthcare-associated pneumonia |
Clinical Assistant Professor - Temple University School of Pharmacy |
| Adrienne Terico, PharmD, BCPS, BCIDP | 2013-14 | A comparison of patients with methicillin-susceptible Staphylococcus aureusbacteremia who receive empiric vancomycin compared with those who receive a regimen containing an active beta-lactam | Clinical Pharmacist, Infectious Diseases - Jefferson ARIA |
| Jessica Gallagher, PharmD, BCPS | 2014-15 | An evaluation of the effectiveness of double-carbapenem-based therapy for carbapenem-resistant Klebsiella pneumoniaeinfections. |
Clinical Pharmacist, Infectious Diseases - Virtua Health
Clinical Pharmacy Specialist, Infectious Diseases - Lankenau Medical Center |
| Madeline King, PharmD, BCPS, BCIDP | 2015-16 | Ceftazidime/avibactam for carbapenem-resistant Enterobacteriaceaeinfections: a multicenter experience | Assistant Professor - University of the Sciences |
| Alexandra Hanretty, PharmD | 2016-17 | A comparison of nephrotoxicity rates between polymyxin-containing regimens and beta-lactam-based regimens for multidrug resistant Gram-negative rod infections | Clinical Pharmacist, Infectious Diseases - St. Christopher’s Hospital for Children |
| Ann Marie Porreca, PharmD, BCPS, BCIDP | 2017-18 | An assessment of the impact of MALDI-TOF without additional antimicrobial stewardship support. | Clinical Pharmacist, Infectious Diseases - St. Luke’s Medical Center |
| Maria Heaney, PharmD | 2018-19 | A comparison of treatment patterns of coagulase-negative staphylococcal positive blood cultures before and after instituting MALDI-TOF | Current resident |